{"id":"https://openalex.org/W7202397346","doi":"https://doi.org/10.25258/ijddt.16.74s.131","title":"Synthesis, spectral characterizations and molecular docking studies of Montelukast Methyl Ketone, Lacosamide derivatives as promising antibacterial agents and antiviral activity towards New Castle Disease Virus (NDV) using Embryonated Chicken Eggs Assay (ECEA)","display_name":"Synthesis, spectral characterizations and molecular docking studies of Montelukast Methyl Ketone, Lacosamide derivatives as promising antibacterial agents and antiviral activity towards New Castle Disease Virus (NDV) using Embryonated Chicken Eggs Assay (ECEA)","publication_year":2026,"publication_date":"2026-08-12","ids":{"openalex":"https://openalex.org/W7202397346","doi":"https://doi.org/10.25258/ijddt.16.74s.131"},"language":"en","primary_location":{"id":"doi:10.25258/ijddt.16.74s.131","doi":"https://doi.org/10.25258/ijddt.16.74s.131","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.74s.131","pdf_url":"https://doi.org/10.25258/ijddt.16.74s.131","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.25258/ijddt.16.74s.131","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106380416","display_name":"S. Bakyalakshmi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Bakyalakshmi","raw_affiliation_strings":["PG & Research Department of Chemistry, Arignar Anna Govt. Arts and Science College Cheyyar, Tamilnadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PG & Research Department of Chemistry, Arignar Anna Govt. Arts and Science College Cheyyar, Tamilnadu, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147085682","display_name":"N. Elumalai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Elumalai","raw_affiliation_strings":["PG & Research Department of Chemistry, Arignar Anna Govt. Arts and Science College Cheyyar, Tamilnadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PG & Research Department of Chemistry, Arignar Anna Govt. Arts and Science College Cheyyar, Tamilnadu, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101574994","display_name":"CT. Ravichandran","orcid":"https://orcid.org/0000-0001-7812-6234","observed_orcids":["https://orcid.org/0000-0001-7812-6234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CT. Ravichandran","raw_affiliation_strings":["PG & Research Department of Chemistry, Arignar Anna Govt. Arts and Science College Cheyyar, Tamilnadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PG & Research Department of Chemistry, Arignar Anna Govt. Arts and Science College Cheyyar, Tamilnadu, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.45330829,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"74s","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3296000063419342,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3296000063419342,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.10589999705553055,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.05290000140666962,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heterocyclic-compounds","display_name":"heterocyclic compounds","score":0.7789999842643738},{"id":"https://openalex.org/keywords/antibacterial-activity","display_name":"antibacterial activity","score":0.9459999799728394},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.9900000095367432},{"id":"https://openalex.org/keywords/newcastle-disease-virus","display_name":"Newcastle disease virus","score":0.968999981880188},{"id":"https://openalex.org/keywords/velogenic-ndv","display_name":"velogenic NDV","score":0.6970000267028809},{"id":"https://openalex.org/keywords/hemagglutination-inhibition","display_name":"hemagglutination inhibition","score":0.8169999718666077},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.6010000109672546},{"id":"https://openalex.org/keywords/absence-seizures","display_name":"absence seizures","score":0.7450000047683716},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.6050000190734863},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.460999995470047},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5730000138282776},{"id":"https://openalex.org/keywords/large-scale-synthesis","display_name":"large-scale synthesis","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C129470801","wikidata":"https://www.wikidata.org/wiki/Q5370234","display_name":"Embryonated","level":3,"score":0.8603000044822693},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5769000053405762},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5647000074386597},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5532000064849854},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.4555000066757202},{"id":"https://openalex.org/C2778139780","wikidata":"https://www.wikidata.org/wiki/Q420077","display_name":"Lacosamide","level":3,"score":0.44830000400543213},{"id":"https://openalex.org/C2780104969","wikidata":"https://www.wikidata.org/wiki/Q4774530","display_name":"Antibacterial activity","level":3,"score":0.3824000060558319},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3686999976634979},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35190001130104065},{"id":"https://openalex.org/C2778116459","wikidata":"https://www.wikidata.org/wiki/Q327082","display_name":"Newcastle disease","level":3,"score":0.3463999927043915},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.31790000200271606},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.2924000024795532},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2653000056743622},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.2630000114440918},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.2597000002861023},{"id":"https://openalex.org/C89138240","wikidata":"https://www.wikidata.org/wiki/Q3066564","display_name":"Vero cell","level":3,"score":0.2578999996185303},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25258/ijddt.16.74s.131","doi":"https://doi.org/10.25258/ijddt.16.74s.131","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.74s.131","pdf_url":"https://doi.org/10.25258/ijddt.16.74s.131","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25258/ijddt.16.74s.131","doi":"https://doi.org/10.25258/ijddt.16.74s.131","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.74s.131","pdf_url":"https://doi.org/10.25258/ijddt.16.74s.131","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202397346.pdf","grobid_xml":"https://content.openalex.org/works/W7202397346.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W1976388593","https://openalex.org/W2025185593","https://openalex.org/W7155560704"],"related_works":["https://openalex.org/W4413217850","https://openalex.org/W7214075917","https://openalex.org/W2955800174","https://openalex.org/W2157241207","https://openalex.org/W2558946402","https://openalex.org/W7049334229","https://openalex.org/W3008044990","https://openalex.org/W6977029038","https://openalex.org/W2995858049","https://openalex.org/W3119049457"],"abstract_inverted_index":{"In":[0],"the":[1,6,17,34,46,50,68,82,92,111,146,176,198,250,283,302,363,371,381,400,416,432],"present":[2,41],"study,":[3],"we":[4],"report":[5],"synthesis":[7],"of":[8,19,32,52,70,78,85,96,120,148,157,179,191,200,210,233,243,252,269,280,304,341,385,393,399],"montelukast":[9,20,71,86,254,372],"methyl":[10,255,373],"ketone,":[11],"lacosamide":[12,97,376],"derivatives.The":[13],"scalable":[14],"procedure":[15],"for":[16,23,67,133,141,241,313,332],"generation":[18,171],"(Singulair,":[21],"drug":[22,102,173],"asthma)":[24],"based":[25],"on":[26],"a":[27,106,118,169,206],"novel":[28],"and":[29,54,61,80,87,94,135,155,164,213,345,388,429],"useful":[30],"way":[31],"performing":[33],"key":[35],"substitution":[36],"reaction":[37],"has":[38],"been":[39,238],"presented.The":[40],"approach":[42,66],"is":[43,72,168,217],"recognized":[44],"from":[45,113,253,308],"prior":[47,188],"solutions":[48],"in":[49,99,105,110,203,334,360],"application":[51],"inexpensive":[53],"accessible":[55],"materials,":[56],"which":[57],"ensures":[58],"very":[59],"simple":[60],"economic":[62,224],"production":[63,69,84],"method.Our":[64],"suggested":[65],"capable":[73],"to":[74,189,196,362,380,436],"minimize":[75],"an":[76,265],"amount":[77],"impurities":[79],"lets":[81],"efficient":[83],"its":[88],"scale-up.We":[89],"retrospectively":[90],"studied":[91,183],"efficacy":[93],"tolerability":[95],"(LCM)":[98,167],"children":[100],"with":[101,117,277,292],"resistant":[103],"epilepsy":[104,212],"tertiary":[107],"care":[108],"centre":[109],"Netherlands,":[112],"2013":[114],"till":[115],"2019,":[116],"follow-up":[119],"two":[121],"years.79":[122],"children,":[123],"aged":[124],"<":[125],"18":[126],"years,":[127],"were":[128,137,150,159,275,290,330,407,418,434],"included.Retention":[129],"rate,":[130],"effectiveness,":[131],"reason":[132],"termination":[134],"side-effects":[136,149],"analyzed.Furthermore,":[138],"prognostic":[139],"variables":[140],"discontinuation":[142],"as":[143,145],"well":[144],"incidence":[147],"determined.The":[151],"LCM":[152,186],"retention":[153],"rate":[154,303,320],"effectiveness":[156],"response":[158],"analyzed":[160],"at":[161],"three,":[162],"twelve":[163],"twenty-four":[165],"months.Lacosamide":[166],"new":[170],"antiepileptic":[172],"that":[174,317,370],"affects":[175],"slow":[177],"inactivation":[178],"voltage-gated":[180],"sodium":[181],"channels.We":[182],"whether":[184],"chronic":[185],"treatment":[187,242],"onset":[190],"absence":[192,201,211],"seizures":[193,202],"was":[194,311,321],"able":[195],"prevent/reduce":[197],"development":[199],"GAERS":[204],"rats,":[205],"well-validated":[207],"animal":[208],"model":[209],"epilepto":[214],"genesis.Newcastle":[215],"disease":[216,221,261],"highly":[218],"infectious":[219],"viral":[220,234],"causing":[222],"huge":[223],"losses":[225,227],"worldwide.These":[226],"can":[228],"be":[229],"prevented":[230],"by":[231,264,391,421],"control":[232,288],"diseases.Medicinal":[235],"plants":[236],"have":[237,437],"traditionally":[239],"used":[240],"different":[244,281,299],"diseases":[245],"since":[246],"long.In":[247],"this":[248],"study":[249],"effect":[251],"ketone":[256,374],"are":[257],"investigated":[258],"against":[259,338,355],"Newcastle":[260],"virus":[262],"(NDV)":[263],"in-vivo":[266],"assay.Seven":[267],"groups":[268,284,297],"nine-day-old":[270],"embryo":[271,305,318],"nated":[272],"chicken":[273],"eggs":[274,310],"inoculated":[276,291],"various":[278],"treatments":[279],"concentration.All":[282],"except":[285],"uninoculated":[286],"negative":[287,344],"group":[289],"velogenic":[293],"NDV":[294],"strain;":[295],"five":[296],"received":[298],"concentrations.Daily":[300],"observe":[301],"survival.Allantoic":[306],"fluid":[307],"treated":[309,324],"collected":[312],"hemagglutination":[314],"test.Results":[315],"showed":[316],"survival":[319],"higher":[322],"300\u03bcg/ml":[323],"antiviral":[325,408],"activity.The":[326],"synthesized":[327],"heterocyclic":[328],"compounds":[329],"evaluated":[331],"their":[333],"vitro":[335],"antibacterial":[336,353],"activity":[337,354,409],"pathogenic":[339],"strains":[340],"both":[342],"gram":[343,346],"positive":[347],"bacteria.The":[348],"3a":[349],"derivative":[350,377],"displayed":[351],"superior":[352],"E.":[356,389],"coli,":[357],"Pseudomonas":[358],"aeruginosa":[359,387],"comparison":[361],"reference":[364],"drug.The":[365],"molecular":[366],"docking":[367],"studies":[368],"indicate":[369],"(3a),":[375],"(3b)":[378],"binds":[379],"cell":[382,402],"wall":[383,403],"protein":[384],"P.":[386],"coli":[390],"formation":[392],"amino":[394],"acid":[395],"residues":[396],"(GLU342,":[397],"LEU398)":[398],"bacterial":[401],"protein.The":[404],"3b":[405],"derivatives":[406],"towards":[410],"New":[411],"Castle":[412],"Disease":[413],"Virus":[414],"(NDV).All":[415],"products":[417,433],"thoroughly":[419],"characterized":[420],"1":[422],"H-NMR,":[423],"13":[424],"C-NMR,":[425],"FT-IR,":[426],"Mass":[427],"spectral":[428],"CHN":[430],"analysis.All":[431],"found":[435],"good":[438],"oral":[439],"bioavailability.":[440]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-08-14T00:00:00"}